Brief: Myriad Genetics Announces Select Preliminary Fourth Quarter And Full Year 2025 Financial Results And Introduces Full Year 2026 Financial Guidance
12/01/2026 13:33
Jan 12 (Reuters) - Myriad Genetics Inc MYGN.O: MYRIAD GENETICS ANNOUNCES SELECT PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND INTRODUCES FULL YEAR 2026 FINANCIAL GUIDANCE MYRIAD GENETICS INC - Q4 2025 REVENUES EXPECTED BETWEEN $207 MILLION AND $209 MILLION MYRIAD GENETICS INC - FULL YEAR 2025 REVENUES EXPECTED BETWEEN $822 MILLION AND $824 MILLION MYRIAD GENETICS INC - 2026 REVENUE GUIDANCE BETWEEN $860 MILLION AND $880 MILLION Source text: ID:nGNXbfgbtv Further company coverage: MYGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple